CClinicalTrials.gg
TerminatedNCT04964674Updated Sep 27, 2024

Psychometric Testing and Cue Utilization During Cued Visual Search

An interventional study of Behavioral Measurement in Healthy, sponsored by Lehigh University. Terminated at 1 site in United States. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-09-27.

Sponsored by Lehigh University · Not applicable, Interventional, and Basic science

Why this study was terminated
Attempts at online data collection led to poor data quality (many missing data points from one task of the set). Study was terminated, given the data quality issues.
Phase
Not applicable
Study type
Interventional
Enrollment
122
Allocation
Not applicable
Ages
18 Years and older
Sex
All
01

Study summary

The experimenters will examine the relationship between utilization of positive (target cue) and negative (distractor cue) templates during a cued visual search task with performance on a set of measures related to executive functions associated with attentional control: shifting, updating, and inhibition.

Read the detailed description

The experimenters will utilize the typical procedures for the cued attentional task, while also deploying the Miyake executive function analysis. Data will also include a working memory capacity measure.

02

Conditions studied

  • Healthy

Keywords

  • attention
  • visual search
03

In context

Lead sponsor

Lehigh University is the lead sponsor of 16 studies on the registry; 5 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Normal or corrected-to-normal visual acuity, normal color vision

Exclusion criteria

Exclusion Criteria:

  • age
05

Study design

Phase
Not applicable
Primary purpose
Basic science
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
122 participants (actual)

Study arms

  • Experimental
    Attentional Tests- Miyake and others

    All participants will complete a series of behavioral tasks, including cued visual search with positive, negative, and neutral cues, Miyake executive attention tasks, and a visual working memory task. Single Arm.

    Behavioral: Behavioral Measurement

Interventions

  • BehavioralBehavioral Measurement

    Take measurements of behavioral performance

06

What researchers measure

Primary outcomes

  1. Positive, Negative, Neutral Attention Task Performance Speed

    Reaction times on visual search task with positive, negative, and neutral cues

    Time frame: 1 day

  2. Positive, Negative, Neutral Attention Task Performance Accuracy

    Accuracy on visual search task with positive, negative, and neutral cues

    Time frame: 1 day

  3. Miyake Executive Attention task- Updating

    Updating Attention

    Time frame: 1 day

  4. Miyake Executive Attention task-Shifting

    Shifting Attention

    Time frame: 1 day

  5. Miyake Executive Attention task-Inhibition

    Inhibition of attention

    Time frame: 1 day

  6. Working Memory Capacity

    Estimate of working memory capacity based on behavioral performance

    Time frame: 1 day

07

Study locations

1 site
  • Lehigh University
    Bethlehem, Pennsylvania 18015, United States
08

References and documents

Publications

  • Arita JT, Carlisle NB, Woodman GF. Templates for rejection: configuring attention to ignore task-irrelevant features. J Exp Psychol Hum Percept Perform. 2012 Jun;38(3):580-4. doi: 10.1037/a0027885. Epub 2012 Apr 2. PubMed 22468723 ↗
  • Miyake A, Friedman NP, Emerson MJ, Witzki AH, Howerter A, Wager TD. The unity and diversity of executive functions and their contributions to complex "Frontal Lobe" tasks: a latent variable analysis. Cogn Psychol. 2000 Aug;41(1):49-100. doi: 10.1006/cogp.1999.0734. PubMed 10945922 ↗

Individual participant data

Plan to share: Yes — Anonymous behavioral performance data will be available for other researchers upon request

Supporting information: Study protocol, Analytic code

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 27, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04964674
Lead sponsor
Lehigh University
Responsible party
Sponsor
First posted
Jul 16, 2021
Start date
Apr 12, 2021
Primary completion
Aug 27, 2022
Completion
Aug 27, 2022
Last update
Sep 27, 2024

Study contacts

Nancy Carlisle, PhD
principal investigator · Lehigh University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is terminated, as verified in Sep 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion